GSK Next, the innovation arm of GlaxoSmithKlein, is launching a new mentorship and business development program. Called the Re/Wire Health Studio, the program will eventually select six startups who will win access to nine weeks of mentoring, business development expertise, and cash grants.
The Re/Wire Health Studio is designed for growth and early-stage startups focused on “everyday health.” That means products that aid in detecting long-term health problems, incentivize proactive care, or help someone manage a condition, for example. Under the umbrella of “everyday health” the studio will work with startups applying everyday health principals to three areas of focus: oral health, mental resilience, or women’s health.
Companies from all over the world can apply, but they must be prepared to launch in the U.S. with a minimum viable product, or be ready to perform in-market development. Applications close September 20, 2021, and the full cohort will be announced in October.
The Re/Wire Health studio is a joint project between the GSK and R/GA Ventures – which will act as the Studio’s operational partner and help select the cohort.
TechCrunch spoke with Nick Tate, the Vice President of Global Digital Innovation at GSK Consumer Healthcare and head of GSK Next, to talk about what he looks for in a startup, what selected companies will gain from participation, and the types of projects he’s excited to hear more about.
Continue to the full article in TechCrunch.